Resonance Health Limited
RHT
Rank in Stocks
#25579
Resonance Health Limited is a global provider of healthcare technology and... Resonance Health Limited is a global provider of healthcare technology and services, specializing in the design, development, and production of software-as-medical devices. The company serves markets across the Asia Pacific, Americas, Europe, Middle East, and Africa. Its portfolio of non-invasive, MRI-based diagnostic tools includes FerriScan, a system for quantifying liver iron concentration (LIC); FerriSmart, leveraging artificial intelligence (AI) for automated, real-time assessment of LIC; HepaFat-AI, an AI-driven solution for real-time, multi-metric liver fat quantification; CardiacT2, which provides dual analysis in conjunction with FerriScan to evaluate cardiac iron accumulation; HepaFat-Scan, a non-invasive MRI method for assessing liver fat within tissue; and LiverSmart, a comprehensive non-invasive MRI device integrating FerriSmart and HepaFat-AI for a unified report. The company further extends its offerings to include quantitative imaging measurements and Contract Research Organization (CRO) services, encompassing rigorous image analysis, imaging charter development, robust project and data management, proactive issue resolution, site tracking with clinical trial progress reports, and streamlined data flow coordination. They also provide comprehensive biomarker services, covering analysis of blood, urine, and protein analytes, alongside RNA, DNA, and genotyping. Their support for multinational and multicenter clinical trials extends to protocol development, subject inclusion/exclusion criteria assessment, dose modification strategies, new therapy safety profile evaluations, and establishing primary and secondary endpoints for drug efficacy. Additionally, they supply phantoms crucial for MRI machine calibration. Its client base includes clinicians, who utilize their solutions for managing human diseases, and pharmaceutical and therapeutic companies engaged in clinical research. Established in 1987, Resonance Health Limited maintains its headquarters in Burswood, Australia.
Share Price
$0.05260644
Last synced: 2026-11-09
Market Cap
$25.10M
Change (1 day)
-1.48%
Change (1 year)
61.23%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Resonance Health Limited (RHT)
Category
Healthcare
Operating Margin for Resonance Health Limited (RHT)
Operating Margin as of November 2026 TTM: 9.72%
According to Resonance Health Limited's latest financial reports, its current operating margin (TTM) is 9.72%. At the end of 2025 the company had an operating margin of -17.42%.
Operating Margin history for Resonance Health Limited from 2000 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 9.72% | -155.80% |
| 2025 | -17.42% | 70.28% |
| 2024 | -10.23% | -72.27% |
| 2023 | -36.89% | -20.31% |
| 2022 | -46.29% | -1,029.52% |
| 2021 | 4.98% | -115.48% |
| 2020 | -32.17% | -234.49% |
| 2019 | 23.92% | -365.48% |
| 2018 | -9.01% | -64.00% |
| 2017 | -25.03% | 151.05% |
| 2016 | -9.97% | 115.33% |
| 2015 | -4.63% | -244.69% |
| 2014 | 3.20% | -106.98% |
| 2013 | -45.84% | -0.13% |
| 2012 | -45.90% | 47.07% |
| 2011 | -31.21% | 49.40% |
| 2010 | -20.89% | -208.13% |
| 2009 | 19.32% | -186.87% |
| 2008 | -22.24% | -56.61% |
| 2007 | -51.26% | -95.74% |
| 2006 | -1,203.53% | -53.96% |
| 2005 | -2,614.17% | -95.82% |
| 2004 | -62,606.06% | 0.00% |
| 2003 | 0.00% | 0.00% |
| 2002 | 0.00% | 0.00% |
| 2000 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 13.21% | -98.64% |
US
|
|
| -19.76% | -102.03% |
US
|
|
| 74.94% | -92.29% |
AU
|
|
| 3.61% | -99.63% |
US
|
|
| 13.01% | -98.66% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Resonance Health Limited's operating margin
What is Resonance Health Limited's operating margin?
Resonance Health Limited's operating margin is 9.72%, as of Nov 2026.
What was Resonance Health Limited's operating margin in 2025?
In 2025, Resonance Health Limited's operating margin was -17.42%, compared with -10.23% in 2024.
How has Resonance Health Limited's operating margin changed since 2020?
From 2020 to 2025, Resonance Health Limited's operating margin was highest in 2021 (4.98%) and lowest in 2022 (-46.29%).
How does Resonance Health Limited's operating margin compare with similar companies?
Resonance Health Limited's operating margin (9.72%) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Pro Medicus Limited, with 74.94%.